Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fresenius kabi malaysia sdn. bhd - adalimumab -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fresenius kabi malaysia sdn. bhd - adalimumab -

European Union - English - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - busulfan - hematopoietic stem cell transplantation - alkyl sulfonates - busulfan fresenius kabi followed by cyclophosphamide (bucy2) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation (hpct) in adult patients when the combination is considered the best available option.busulfan fresenius kabi followed by cyclophosphamide (bucy4) or melphalan (bumel) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation in paediatric patients.

European Union - English - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - pemetrexed - carcinoma, non-small-cell lung; mesothelioma - antineoplastic agents - malignant pleural mesotheliomapemetrexed fresenius kabi in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.non-small cell lung cancerpemetrexed fresenius kabi in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.pemetrexed fresenius kabi is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed fresenius kabi is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi austria gmbh - lactulose - oral solution - 670 milligram(s)/millilitre - osmotically acting laxatives; lactulose

European Union - English - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - bortezomib - multiple myeloma - antineoplastic agents - bortezomib as monotherapy or in combination with pegylated liposomal doxorubicin or dexamethasone is indicated for the treatment of adult patients with progressive multiple myeloma who have received at least 1 prior therapy and who have already undergone or are unsuitable for haematopoietic stem cell transplantation.bortezomib in combination with melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for high-dose chemotherapy with haematopoietic stem cell transplantation.bortezomib in combination with dexamethasone, or with dexamethasone and thalidomide, is indicated for the induction treatment of adult patients with previously untreated multiple myeloma who are eligible for high-dose chemotherapy with haematopoietic stem cell transplantation.bortezomib in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.

European Union - English - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuscular blockade - all other therapeutic products - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi deutschland gmbh - soya bean oil ; glucose monohydrate; alanine; arginine ; aspartic acid; glutamic acid ; glycine; histidine; isoleucine; leucine ; lysine hydrochloride; methionine; phenylalanine; proline; serine; threonine; tryptophan; tyrosine; valine; calcium chloride 2 h2o; sodium glycerophosphate anhydrous; magnesium sulphate 7h2o; potassium chloride; sodium acetate 3 h20 ; amino acids; nitrogen; fat; glucose; glucose (dextrose); sodium; potassium; magnesium; calcium; phosphate; sulphate; chloride; acetate - emulsion for infusion - solutions for parenteral nutrition; combinations

Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - alanine; arginine; fish oil, rich in omega -3 acids; glucose monohydrate; glycine; histidine; isoleucine; leucine; lysine acetate; methionine; olive oil, refined; phenylalanine; proline; serine; soya bean oil, refined; taurine; threonine; triglycerides, medium chain; tryptophan; tyrosine; valine - injection, emulsion - 14.0g/1000ml - alanine 14.0g/1000ml; arginine 12.0g /1000ml; fish oil, rich in omega -3 acids 30g /1000ml; glucose monohydrate 462g /1000ml; glycine 11.0g /1000ml; histidine 3.0g /1000ml; isoleucine 5.0g /1000ml; leucine 7.4g /1000ml; lysine acetate 9.3g /1000ml; methionine 4.3g /1000ml; olive oil, refined 50g /1000ml; phenylalanine 5.1g /1000ml; proline 11.2g /1000ml; serine 6.5g /1000ml; soya bean oil, refined 60.0g /1000ml; taurine 1.0g /1000ml; threonine 4.4g /1000ml; triglycerides, medium chain 60g /1000ml; tryptophan 2.0g/1000ml; tyrosine 0.4g /1000ml; valine 6.2g /1000ml

Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - alanine; arginine; calcium chloride dihydrate; fish oil, rich in omega -3 acids; glucose monohydrate; glycine; histidine; isoleucine; leucine; lysine acetate; magnesium sulphate heptahydrate; methionine; olive oil, refined; phenylalanine; potassium chloride; proline; serine; sodium acetate trihydrate; sodium glycerophosphate anhydrous; soya bean oil, refined; taurine; threonine; triglycerides, medium chain; tryptophan; tyrosine; valine; zinc sulphate heptahydrate - injection, emulsion - 14.0g/1000ml - alanine 14.0g/1000ml; arginine 12.0g /1000ml; calcium chloride dihydrate 0.74g /1000ml; fish oil, rich in omega -3 acids 30g /1000ml; glucose monohydrate 462g /1000ml; glycine 11.0g /1000ml; histidine 3.0g /1000ml; isoleucine 5.0g /1000ml; leucine 7.4g /1000ml; lysine acetate 9.3g /1000ml; magnesium sulphate heptahydrate 2.47g /1000ml; methionine 4.3g /1000ml; olive oil, refined 50g /1000ml; phenylalanine 5.1g /1000ml; potassium chloride 4.48g /1000ml; proline 11.2g /1000ml; serine 6.5g /1000ml; sodium acetate trihydrate 5.62g /1000ml; sodium glycerophosphate anhydrous 4.18g /1000ml; soya bean oil, refined 60.0g /1000ml; taurine 1.0g /1000ml; threonine 4.4g /1000ml; triglycerides, medium chain 60g /1000ml; tryptophan 2.0g/1000ml; tyrosine 0.4g /1000ml; valine 6.2g /1000ml; zinc sulphate heptahydrate 0.023g /1000ml